(0.75%) 5 120.25 points
(0.13%) 38 339 points
(0.98%) 17 740 points
(0.83%) $84.26
(-6.59%) $1.530
(0.55%) $2 355.30
(0.79%) $27.57
(0.58%) $925.80
(0.13%) $0.933
(0.54%) $11.01
(0.00%) $0.799
(-0.60%) $91.61
Live Chart Being Loaded With Signals
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States...
Stats | |
---|---|
Today's Volume | 11.93M |
Average Volume | 2.95M |
Market Cap | 1.14B |
EPS | $-0.180 ( 2023-11-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.25 |
ATR14 | $0.0660 (2.82%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-09 | Casdin Eli | Sell | 5 488 164 | Common Stock |
2023-11-09 | Casdin Eli | Sell | 8 110 001 | Warrants to purchase Class A Common Stock (right to buy) |
2023-11-09 | Casdin Eli | Sell | 755 766 | Earn-out Shares |
2023-11-09 | Casdin Eli | Sell | 101 010 | Stock Option (Right to Buy) |
2023-11-09 | Nallicheri Melanie | Buy | 626 999 | Common Stock |
INSIDER POWER |
---|
-96.17 |
Last 94 transactions |
Buy: 76 186 838 | Sell: 93 441 879 |
Volume Correlation
EQRx, Inc. Correlation
10 Most Positive Correlations | |
---|---|
BSRR | 0.931 |
MPAA | 0.931 |
CLGN | 0.931 |
ENG | 0.929 |
CNSP | 0.929 |
CPTN | 0.927 |
VBTX | 0.926 |
MYFW | 0.926 |
UBFO | 0.925 |
BPYPN | 0.924 |
10 Most Negative Correlations | |
---|---|
RMBS | -0.899 |
LYTS | -0.898 |
DSPG | -0.897 |
CCRC | -0.895 |
KE | -0.894 |
JMPNZ | -0.893 |
ISDX | -0.893 |
PPYAU | -0.892 |
IEUS | -0.891 |
HEWG | -0.89 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
EQRx, Inc. Correlation - Currency/Commodity
EQRx, Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $0.430 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $0.430 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.205 |
FY | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.513 |
Financial Reports:
No articles found.
EQRx, Inc.
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EGFR-mutated non-small cell lung cancer (NSCLC); and Sugemalimab, an anti-programmed death-ligand 1 antibody for the treatment of Stage III and Stage IV NSCLC. Its other programs in pipeline include clinical and pre-clinical stage assets, which comprise Lerociclib, a small molecule cyclin-dependent kinase 4/6 inhibitor, which is in Phase II clinical trials in patients with metastatic breast cancer; EQ176, an anti-programmed death-1 antibody that is in Phase III trials for the treatment of patients with primary liver cancer; and EQ121, a selective janus kinase-1 inhibitor that is in various Phase I trials. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators